The U.K. NorthStar Clinical Network
This study, called the NorthStar Clinical Network, is looking at how Duchenne Muscular Dystrophy (DMD) affects people in the UK from childhood to adulthood. It's a 'natural history' study, meaning it observes how the condition progresses naturally, without testing new medicines. Researchers will collect information on patients' movement, breathing, heart health, bone strength, and how DMD impacts daily life. They also want to understand things like learning differences, puberty changes, and general well-being. This information will help doctors and scientists understand DMD better, which is crucial for developing and testing new treatments in the future.
At a glance
What is this study about?
This study, called the U.K. NorthStar Clinical Network, is all about understanding Duchenne Muscular Dystrophy (DMD) in young people and adults across the United Kingdom. It's an 'observational' study, which means researchers aren't testing any new treatments or medicines. Instead, they are carefully watching and recording how DMD changes and develops in people over time. Think of it like taking a detailed long-term photograph of the condition's journey.
The main goal is to collect information on how DMD affects things like movement (walking, standing) and breathing as people get older. But they're also looking at many other important aspects of health. This includes heart health, bone strength, hormone changes during puberty, spinal curvature (scoliosis), and how the condition might impact learning, behaviour, and overall quality of life. They will also gather information on people's background, like their ethnicity.
By gathering all this detailed information from many people with DMD, the study aims to create a much clearer picture of how the condition affects people at different stages of their lives. This knowledge is incredibly important. It helps doctors understand what to expect, and it's essential for researchers when they are trying to develop and test new medicines or therapies for DMD in the future.
Key takeaways
- It's an observational study to understand Duchenne Muscular Dystrophy (DMD) over time.
- No new treatments or medicines are given; it tracks how DMD progresses naturally.
- Information gathered supports future research and development of new therapies.
- Involves annual or bi-annual visits to a specialist clinic for assessments.
- Open to males with a confirmed DMD diagnosis living in the UK.
- Participation in other trials doesn't stop you from joining this one.
Who may be eligible?
This study is specifically for males in the United Kingdom who have been diagnosed with Duchenne Muscular Dystrophy (DMD). This diagnosis usually needs to be confirmed by a genetic test.
Even if the genetic test is still being processed, you might still be able to join if your diagnosis was made through a muscle biopsy.
Good news – if you're already taking part in another clinical trial or have had surgery, you can still join this study. This is because it's about observing your condition and not about giving you a new treatment. However, you can't join if you live outside the United Kingdom.
- Are you male?
- Do you have a genetically confirmed diagnosis of Duchenne Muscular Dystrophy?
- Do you live in the United Kingdom?
- Are you willing to attend annual or bi-annual clinic appointments?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you'll visit your specialist muscle clinic once or twice a year. During these visits, the study team will carry out a series of assessments. These will include check-ups related to your movement and physiotherapy, breathing tests, and some questions about your general health and how DMD affects your daily life. The team will also record important medical details.
All the information collected from your visits and questionnaires will then be securely added to a special national database. There are no new medications involved; you'll continue with any treatments you're already receiving. The study aims to follow participants over many years to understand the long-term journey of DMD.
Potential risks and benefits
Locations (26)
- Aberdeen, NHS GrampianAberdeen, United Kingdom
- Belfast Health and Social Care TrustBelfast, United Kingdom
- Birmingham Children's HospitalBirmingham, United Kingdom
- Birmingham Community Healthcare NHS Foundation TrustBirmingham, United Kingdom
- Birmingham Heartlands HospitalBirmingham, United Kingdom
- University Hospitals Bristol and WestonBristol, United Kingdom
- Cambridge University HospitalsCambridge, United Kingdom
- Cardiff and Vale University Health BoardCardiff, United Kingdom
- NHS Dundee - TaysideDundee, United Kingdom
- NHS Greater Glasgow and ClydeGlasgow, United Kingdom
- Lancashire Teaching Hospitals NHS Foundation TrustLancaster, United Kingdom
- Leeds Teaching Hospitals NHS TrustLeeds, United Kingdom
+14 more sites — see the official record for the full list.
Common questions
What is a 'natural history' study?
It's a study that observes how a condition, like DMD, changes over time without giving any new treatments. It helps us understand the typical journey of the illness.
Will I receive any new treatment if I join?
No, this study is about observation, not about testing new medicines. You will continue with any standard care you usually receive.
How often do I need to visit the clinic?
You would typically need to attend your specialist muscle clinic once or twice a year for assessments.
What kind of information will be collected about me?
They'll collect details about your movement, breathing, heart health, general health, bone strength, learning, and quality of life through assessments and questionnaires.
What happens to the information collected?
All your information is securely added to a national database to help researchers better understand Duchenne Muscular Dystrophy.
How to find out more
Dr Adnan Manzur, FRCPCH
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.